RELMADA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other
RELMADA THERAPEUTICS, INC. (RLMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other of 1.02 million shares for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther · last filed 2020-08-12
- RELMADA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, other for the quarter ending 2020-06-30 was -136.72K shares.
- RELMADA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, other for the quarter ending 2020-03-31 was 1.16M shares.
- RELMADA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, other for the quarter ending 2019-09-30 was 279.63K shares.
- RELMADA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, other for the quarter ending 2016-03-31 was -29.50K shares.
- RELMADA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, other for fiscal 2017 was 4.11M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other 12 month |
|---|---|---|---|---|---|
| 2020-06-30 | -136.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 1.02M shares 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | 1.16M shares 10-Q · filed 2020-05-15 | ||||
| 2019-09-30 | 279.63K shares 10-Q · filed 2019-11-13 | ||||
| 2017-06-30 | 4.11M shares 10-K · filed 2017-09-28 | ||||
| 2017-01-31 | 2.50M shares 10-K · filed 2017-09-28 | ||||
| 2016-03-31 | -29.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | -81.03K shares derived: sum of 2 quarters · filed 2016-05-09 | 683.60K shares 10-Q · filed 2016-05-09 | ||
| 2015-12-31 | -51.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05 | 713.10K shares 10-Q · filed 2016-02-05 | |||
| 2015-09-30 | 764.62K shares 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |